Relx Plc (NYSE:RELX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eight brokerages that are currently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company.
A number of brokerages recently commented on RELX. Morgan Stanley lowered Relx from an “overweight” rating to an “equal weight” rating in a report on Thursday, May 7th. The Goldman Sachs Group began coverage on Relx in a research report on Wednesday, June 3rd. They set a “buy” rating for the company. Barclays reiterated an “overweight” rating on shares of Relx in a research note on Friday, July 24th. Wall Street Zen downgraded shares of Relx from a “buy” rating to a “hold” rating in a report on Sunday, May 17th. Finally, Weiss Ratings upgraded shares of Relx from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, August 7th.
Read Our Latest Analysis on Relx
Institutional Inflows and Outflows
Relx Stock Performance
Shares of NYSE RELX opened at $34.58 on Thursday. The company has a debt-to-equity ratio of 5.23, a quick ratio of 0.40 and a current ratio of 0.45. The stock’s 50 day moving average price is $33.60 and its 200-day moving average price is $33.67. Relx has a twelve month low of $27.57 and a twelve month high of $48.97.
Relx Cuts Dividend
The business also recently disclosed a dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Friday, August 7th will be given a $0.2785 dividend. The ex-dividend date of this dividend is Friday, August 7th. This represents a yield of 157.0%.
Relx Company Profile
RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.
RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.
Featured Stories
- Five stocks we like better than Relx
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.
